Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • L-NAME Hydrochloride: Precision NOS Inhibition in Vascular R

    2026-04-14

    L-NAME Hydrochloride: Precision NOS Inhibition in Vascular Research

    Understanding the Principle: L-NAME Hydrochloride as a NOS Inhibitor

    L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) is a competitive inhibitor targeting nitric oxide synthase (NOS) enzymes, including neuronal, endothelial, and inducible isoforms. By mimicking L-arginine, it blocks the catalytic formation of nitric oxide (NO)—a pivotal signaling molecule that regulates vascular tone, modulates gene transcription, and influences apoptosis and inflammation signaling (source: vascular tone regulation studies). The ability of L-NAME to reversibly modulate NO production in a dose-dependent manner has positioned it as a critical tool for both in vitro and in vivo cardiovascular disease models, hypertension research, and studies on endothelial dysfunction (product_spec).

    Step-by-Step Experimental Workflows: Optimizing NOS Inhibition

    Robust application of L-NAME Hydrochloride depends on thoughtful protocol design. Below, we break down practical workflows for both cell-based assays and animal models, integrating evidence-backed parameters and troubleshooting insights for reproducibility.

    Protocol Parameters

    • cell culture | 1 mM L-NAME, 24–48 h incubation, 37°C | Inhibition of NO and PGE2 production in high-glucose retinal cells | Delivers consistent suppression of iNOS and COX-2, reducing apoptosis | product_spec
    • animal model (rat, i.v.) | 0.03–300 mg/kg L-NAME | Modulation of systemic arterial blood pressure and bradycardia | Reveals dose-dependent vascular responses reversible by L-arginine rescue | product_spec
    • mesenteric artery strip assay | 10 μM L-NAME, 30 min pre-incubation | Assessment of NO-dependent vs. independent vasorelaxation in isolated vessel preparations | Dissects mechanistic pathways using co-treatment with vasoactive peptides | paper

    Key Innovation from the Reference Study

    The reference study (Yamada et al., 2010) probes the anti-hypertensive peptide rapakinin in spontaneously hypertensive rats. Critically, L-NAME was used to differentiate nitric oxide-dependent vasorelaxation from alternative pathways. While ACE inhibitors typically mediate vasodilation via NO, rapakinin-induced relaxation was only minimally altered by L-NAME, implicating a prostaglandin I2 (PGI2)-IP and CCK1 receptor axis instead. This workflow highlights L-NAME’s value not just as a readout for NO involvement, but as a gatekeeper for pathway mapping in vascular pharmacology.

    For practical assay design, this means incorporating L-NAME as a discriminative control to confirm or exclude NO-dependent mechanisms when characterizing novel vasoactive compounds. Co-incubation with L-NAME, alongside COX or receptor antagonists, can robustly parse the contribution of distinct signaling axes (paper).

    Comparative Advantages and Advanced Applications

    L-NAME Hydrochloride from APExBIO delivers several strategic advantages in translational research:

    • Benchmark potency and specificity: With an IC50 of ~70 μM for NOS inhibition, L-NAME enables sensitive titration of NO signaling in both acute and chronic models (product_spec).
    • Versatility across models: Its water solubility (≥27 mg/mL) and DMSO compatibility facilitate application in cell culture, organ bath, and in vivo settings, supporting both short-term and longitudinal studies (complement).
    • Translational bridge: As highlighted in recent reviews (extension), L-NAME is foundational for dissecting the interplay between vascular tone, apoptosis and inflammation modulation, and cardiovascular pathology.
    • Discriminative mechanism mapping: The reference study’s workflow—using L-NAME to parse NO-dependent vs. prostaglandin-dependent responses—can be adapted for screening antihypertensive or anti-inflammatory agents, ensuring that observed phenotypes are accurately attributed to their molecular drivers.

    Workflow Enhancements and Troubleshooting Tips

    • Solution Preparation: Prepare L-NAME Hydrochloride fresh in water or DMSO immediately before use. Avoid ethanol, as the compound is insoluble (product_spec).
    • Storage and Stability: Store solid L-NAME at -20°C. Use working solutions within a single experimental session to avoid degradation and loss of potency (product_spec).
    • Dose Selection: Begin with protocol-recommended concentrations (see Protocol Parameters), but titrate in pilot experiments to account for species, cell type, or pathophysiological context (workflow_recommendation).
    • Phenotypic Rescue: To confirm specificity, co-treat with L-arginine (substrate competition) or apply alternative NOS inhibitors as experimental controls (workflow_recommendation).
    • Interference and Off-targets: If observed vascular or cellular effects persist in the presence of L-NAME, consider COX pathway involvement or alternative receptor systems, as exemplified by the rapakinin study (paper).

    Interlinking Related Resources: Context and Contrast

    Future Outlook: Implications for Cardiovascular and Inflammation Research

    L-NAME Hydrochloride remains the definitive tool for parsing the molecular underpinnings of vascular tone regulation, apoptosis, and inflammation signaling modulation. Its ability to delineate NO-dependent from alternative vasorelaxation mechanisms, as demonstrated in the rapakinin study, underscores its value in both fundamental and translational science (paper). Emerging evidence points to the need for increasingly nuanced controls—combining NOS inhibitors with pathway-specific antagonists—to unravel complex cardiovascular disease mechanisms and optimize therapeutic discovery (extension).

    With the support of trusted suppliers like APExBIO, researchers can expect ongoing improvements in batch quality, solubility, and technical support, enabling reproducible advances in both preclinical and clinical arenas.

    For detailed ordering information and technical support, visit the L-NAME Hydrochloride product page.